Will It Beat Article 15 To Be In Ayushmann Khurrana’s Top 5 Openers?

Chandigarh Kare Aashiqui is geared for a launch this week. Starring Ayushmann Khurrana and Vaani Kapoor in main roles, the movie is a bit offbeat in its idea because it offers with the subject associated to LGBTQ. Let’s dig it into the movie’s field workplace.
Ayushmann‘s final theatrical launch was Shubh Mangal Zyada Zaavdhan, which had arrived in 2020. It was a big-time underperformer on the field workplace however had taken an outstanding opening. Because the actor is prepared along with his theatrical launch after a niche of over a 12 months and a half, all eyes at the moment are set on its opening.
Learning the theatrical releases put up the COVID’s second wave, we predict Chandigarh Kare Aashiqui has the prospect to beat Ayushmann Khurrana’s Article 15 at max. Different movies appear out of the league. Having mentioned that, surpassing Article 15 can be a troublesome process in itself as we have now seen large movies having stars like John Abraham and Salman Khan taking a surprisingly sluggish begin.
The Anubhav Sinha directorial had taken a good begin of 5.02 crores. In a traditional scenario, Chandigarh Kare Aashiqui would have surpassed these numbers like a cakewalk. Nonetheless, the scene completely modified as there’s a 50% occupancy rule in a significant market like Maharashtra. Additionally, a rising variety of omicron instances will show to be a headache for the movie.
Under are Ayushmann Khurrana’s prime openers:
Bala (2019)- 10.15 crores
Dream Lady (2019)- 10.05 crores
Shubh Mangal Zyada Saavdhan (2020)- 9.55 crores
Badhaai Ho (2018)- 7.29 crores
Article 15 (2019)- 5.02 crores
Nautanki Saala (2013)- 3.25 crores
Shubh Mangal Saavdhan (2017)- 2.71 crores
Let’s look forward to this Friday, and see how Ayushmann Khurrana’s Chandigarh Kare Aashiqui opens on the field workplace.
Should Learn: Shehzada: Kartik Aaryan, Kriti Sanon & The Workforce Unite To Start The Night time Schedule For Rohit Dhawan’s Movie
Observe Us: Fb | Instagram | Twitter | Youtube